| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
35,661 |
27,499 |
$4.35M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
48,756 |
42,478 |
$1.89M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,568 |
13,822 |
$607K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,144 |
4,644 |
$201K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,726 |
4,192 |
$172K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,301 |
3,913 |
$167K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,179 |
4,707 |
$118K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,473 |
2,273 |
$100K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,142 |
1,858 |
$75K |
| 99173 |
|
13,443 |
12,547 |
$55K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,271 |
4,008 |
$54K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,231 |
1,196 |
$49K |
| 90670 |
|
2,835 |
2,626 |
$46K |
| 90686 |
|
2,471 |
2,365 |
$44K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
718 |
632 |
$38K |
| 92551 |
|
8,375 |
7,842 |
$34K |
| 90723 |
|
1,814 |
1,675 |
$29K |
| 90680 |
|
2,029 |
1,863 |
$29K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
631 |
491 |
$28K |
| 90647 |
|
1,655 |
1,538 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,014 |
984 |
$21K |
| 92558 |
|
668 |
639 |
$18K |
| 90707 |
|
1,021 |
958 |
$17K |
| 90716 |
|
1,010 |
948 |
$17K |
| 90651 |
|
996 |
947 |
$16K |
| 96127 |
|
4,771 |
4,624 |
$14K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,750 |
1,683 |
$14K |
| 90633 |
|
958 |
894 |
$14K |
| 99460 |
|
240 |
170 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
423 |
378 |
$13K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
219 |
211 |
$12K |
| 83655 |
|
819 |
757 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
108 |
97 |
$10K |
| 90461 |
|
187 |
183 |
$9K |
| 90734 |
|
544 |
520 |
$9K |
| 99462 |
|
327 |
255 |
$8K |
| 54150 |
|
113 |
56 |
$8K |
| 96160 |
|
3,081 |
2,966 |
$7K |
| D1206 |
Topical application of fluoride varnish |
462 |
399 |
$7K |
| 90696 |
|
279 |
274 |
$5K |
| 90620 |
|
267 |
253 |
$4K |
| 96161 |
|
2,339 |
2,232 |
$4K |
| 90715 |
|
222 |
220 |
$4K |
| 0002A |
|
106 |
106 |
$4K |
| 90697 |
|
453 |
409 |
$3K |
| 90674 |
|
406 |
364 |
$3K |
| 90677 |
|
326 |
314 |
$3K |
| 69210 |
|
134 |
66 |
$3K |
| 90671 |
|
290 |
262 |
$2K |
| 0001A |
|
94 |
94 |
$2K |
| 0072A |
|
69 |
69 |
$2K |
| D0145 |
Oral evaluation for a patient under three years of age |
197 |
120 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
69 |
12 |
$2K |
| 0071A |
|
75 |
74 |
$2K |
| 90661 |
|
162 |
138 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
582 |
557 |
$1K |
| 90710 |
|
127 |
121 |
$960.00 |
| 90700 |
|
54 |
54 |
$911.18 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
89 |
82 |
$747.00 |
| 81003 |
|
201 |
190 |
$458.98 |
| 87634 |
|
18 |
14 |
$231.90 |
| 36416 |
|
69 |
67 |
$165.00 |
| 90381 |
|
12 |
12 |
$96.00 |
| 90380 |
|
12 |
12 |
$80.00 |
| 85018 |
|
289 |
268 |
$33.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
70 |
66 |
$0.00 |
| 94761 |
|
89 |
82 |
$0.00 |
| 91307 |
|
106 |
105 |
$0.00 |
| 99000 |
|
18 |
17 |
$0.00 |
| 91300 |
|
220 |
202 |
$0.00 |